Klinicki bolnicki centar Zagreb

Zagreb 10000

1 studies enrolling now · 11 studies all time

What they study most

Arthritis, Psoriatic, Carcinoma, Squamous Cell, Early Breast Cancer, Hemophilia A, Hemophilia A or B, Hemophilia B, PD-L1-selected Solid Tumors, Primary Immune Thrombocytopenia, Relapsing Multiple Sclerosis

Studies at this site

• JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC — Recruiting now
• Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors — Recruiting now
• A Study of Guselkumab in Participants With Active Psoriatic Arthritis — Running, not enrolling
• A Study to Evaluate the Safety and Pharmacokinetics of the Intravenous Fixed-Dose Combination (IV FDC) of Tiragolumab and Atezolizumab in Participants With Locally Advanced, Recurrent or Metastatic Solid Tumors — Completed
• A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) — Running, not enrolling
• A Study to Investigate the Efficacy of Fenebrutinib in Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
• A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone) — Running, not enrolling
• A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia — Completed
• Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B — Completed
• PF-06741086 Long-term Treatment in Severe Hemophilia — Completed
• PF-06741086 Multiple Dose Study in Severe Hemophilia — Completed